Merck & Co., Inc. Logo

Merck & Co., Inc.

A global biopharma developing innovative medicines, vaccines, and animal health products.

MRK | F

Overview

Corporate Details

ISIN(s):
DE0006599905 (+71 more)
LEI:
4YV9Y5M8S0BRK1RP0397
Country:
United States of America
Address:
126 EAST LINCOLN AVENUE, 7065 RAHWAY
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Merck & Co., Inc. is a global, research-intensive biopharmaceutical company dedicated to developing innovative health solutions. With a history spanning over 130 years, the company discovers, develops, manufactures, and markets a broad range of products, including prescription medicines, vaccines, biologic therapies, and animal health products. Merck focuses on scientific innovation to address significant global health challenges, leveraging a robust research pipeline and extensive clinical trials. The company is a leader in various therapeutic areas, particularly oncology and vaccines, aiming to save and improve lives worldwide.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-28 14:26
Declaration of Voting Results & Voting Rights Announcements
English 80.9 KB
2025-11-24 10:50
Declaration of Voting Results & Voting Rights Announcements
English 78.5 KB
2025-11-20 14:25
Declaration of Voting Results & Voting Rights Announcements
English 78.5 KB
2025-11-17 00:00
Regulatory Filings
Q3 statement / Q3 financial report 2025
English 489.3 KB
2025-10-24 15:20
Declaration of Voting Results & Voting Rights Announcements
English 78.0 KB
2025-10-23 17:37
Declaration of Voting Results & Voting Rights Announcements
English 78.0 KB
2025-10-21 09:10
Declaration of Voting Results & Voting Rights Announcements
English 78.0 KB
2025-10-17 18:51
Declaration of Voting Results & Voting Rights Announcements
English 78.0 KB
2025-10-16 09:03
Declaration of Voting Results & Voting Rights Announcements
English 77.8 KB
2025-10-14 08:31
Declaration of Voting Results & Voting Rights Announcements
English 77.8 KB
2025-09-01 00:00
Interim / Quarterly Report
Half-yearly financial report 2025
English 999.9 KB
2025-08-13 17:39
Declaration of Voting Results & Voting Rights Announcements
English 81.2 KB
2025-08-05 23:02
Declaration of Voting Results & Voting Rights Announcements
English 81.2 KB
2025-07-14 15:01
Declaration of Voting Results & Voting Rights Announcements
English 81.2 KB
2025-07-08 18:21
Declaration of Voting Results & Voting Rights Announcements
English 81.2 KB

Automate Your Workflow. Get a real-time feed of all Merck & Co., Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Merck & Co., Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Merck & Co., Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Alkaloid AD Logo
Manufactures pharmaceuticals, cosmetics, and herbal products for professionals and consumers.
North Macedonia
ALK
Alkermes plc. Logo
Develops medicines for CNS disorders like schizophrenia, bipolar, and sleep disorders.
United States of America
ALKS
Allarity Therapeutics, Inc. Logo
Develops personalized cancer drugs using a diagnostic platform to predict patient response.
United States of America
ALLR
ALLERGY THERAPEUTICS PLC Logo
Develops innovative, aluminum-free allergy immunotherapy vaccines for the European market.
United Kingdom
AGY
Alligator Bioscience Logo
Develops immuno-oncology antibody drugs to activate the immune system against hard-to-treat cancers.
Sweden
ATORX
Allogene Therapeutics, Inc. Logo
Developing off-the-shelf CAR T-cell therapies for cancer and autoimmune diseases.
United States of America
ALLO
Almirall S.A. Logo
A global biopharmaceutical company developing innovative medical solutions for skin health.
Spain
ALM
ALNYLAM PHARMACEUTICALS, INC. Logo
Pioneering RNAi gene-silencing therapies for rare genetic and cardiometabolic diseases.
United States of America
ALNY
Alpha Cognition Inc. Logo
Develops and commercializes novel treatments for neurodegenerative diseases like Alzheimer's and ALS.
United States of America
ACOG

Talk to a Data Expert

Have a question? We'll get back to you promptly.